Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Hospital Readmissions for Skin Disease Evaluated

J Am Acad Dermatol; ePub 2018 Aug 22; Arnold, et al

There are significant health care and demographic disparities in hospital readmissions for skin disease, according to a recent study. Researchers performed a retrospective cohort study of dermatology hospitalizations by using the 2014 Nationwide Readmissions Database and found:

  • Readmissions following dermatologic hospitalizations cost the American health care system $1.05 billion in 2014.
  • The 30-day rate of all-cause readmission following the 647,251 weighted index admissions for skin disease was 12.63%.
  • Readmission was most common following hospitalizations for cutaneous lymphomas (39.63%), connective tissue disorders (26.28%), and cutaneous congenital abnormalities (23.86%).
  • Predictors of readmission included public insurance with Medicaid or Medicare, residence in a low-income community, an increased number of chronic conditions, and a large hospital.
  • Urban and rural nonteaching hospitals were protective against readmissions from skin disease.

Citation:

Arnold JD, Crockett RM, Kirkorian AY. Hospital readmissions among patients with skin disease: A retrospective cohort study. [Published online ahead of print August 22, 2018]. J Am Acad Dermatol. doi:10.1016/j.jaad.2018.03.042.